Google
IRTC Stock Analysis — IRHYTHM TECHNOLOGIES INC (Healthcare >> Medical Devices)
IRTC FAQ
What is IRTC's P/E ratio?
IRHYTHM TECHNOLOGIES INC (IRTC) currently trades at a P/E ratio of 701.43.
What is IRTC's ROE?
IRHYTHM TECHNOLOGIES INC reports a Return on Equity (ROE) of -17.23%.
What is IRTC's dividend yield?
IRHYTHM TECHNOLOGIES INC offers a dividend yield of 0.00%.
What is IRTC's Quality Score?
Our AI rates IRTC's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy IRTC?
Our AI Timing Score for IRTC is 64 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does IRTC belong to?
IRHYTHM TECHNOLOGIES INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
IRTC AI Analysis Summary
Our AI summary for IRTC: IRHYTHM TECHNOLOGIES INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 701.43, ROE of -17.23%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 64/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 117.17
Price
-1.91
(-1.60%)
Day Change
|
|
|---|
IRTC, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
42% |
| In Recommendations? | In "Invest - GROWTH" Section |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 117.17 |
| PBV / Sector |
24.27 / -101.57
|
| Earning Per Share | -0.83 |
| PE / Sector |
701.43 / 31.23
|
| PEG or PE/Growth / Sector |
-31.08 / 0.40
|
| Average 1M Daily Value |
62.20 M
|
| Average 1W Daily Value |
71.14 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
54% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:02 |
| Symbol | IRTC |
| Name | IRHYTHM TECHNOLOGIES INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 32.86 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 3,913.26 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 699 8th Street, San Francisco, CA, United States, 94103
Phone: 415 632 5700
Website: https://www.irhythmtech.com
Employees: 2,400
Sector: Healthcare >> Medical Devices
Description: iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
